Joel Isaacson & Co., LLC Moderna, Inc. Transaction History

Joel Isaacson & Co., LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	BUY	$135.66 - $197.02 $13,566 - $19,702	100 Added 7.27%	1,475 $226,000
Q4 2022 Jan 27, 2023	BUY	$118.38 - $210.04 $162,772 - $288,805	1,375 New	1,375 $0
Q4 2021 Jan 19, 2022	SELL	$225.82 - $368.51 $298,534 - $487,170	-1,322 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$221.9 - $484.47 $293,351 - $640,469	1,322 New	1,322 $509,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Joel Isaacson & Co., LLC, based on Form 13F filings with the SEC.

Stay updated on Joel Isaacson & Co., LLC with notifications on news.